Shares in drug company Patheon Inc. gained 15 per cent after it reported a third-quarter profit of $15.5 million, up sharply from a year ago, and increased its revenue guidance for the year. In its outlook for the year, Patheon increased its full-year revenue guidance to more than $735 million. The company had earlier expected revenue to be in excess of $725 million. Patheon shares closed up 41 cents at $3.11 on the TSX.
